February 4 - 9, 2027 at The Royal Sonesta Kaua'i Resort Lihue

Agenda

Thursday, February 4
6:00 AMContinental Breakfast / Introductions and WelcomeS. DeMeester &
S. Spechler
Session 1: GERD and Esophageal Diagnostics (5.25 CME)   Moderator: G. Campos
6:45 AMThe spectrum of GERD and global distributionS. Spechler
7:15 AMDiscussion
7:30 AMGERD evaluation: options and when to use themP. Katz
8:00 AMDiscussion
8:15 AMIf I was… (20 minutes each)
• A surgeon, how would I manage my GERD patients?J. Pandolfino
• A GI, how would I manage my GERD patients?S. DeMeester
9:00 AMDiscussion
9:15 AMPathogenesis of GERD, cardiac mucosa and intestinal metaplasiaR. Souza
10:00 AMDiscussion
10:15 AMCoffee Break / Case Presentations
10:30 AMEGD in the evaluation and follow-up of bariatric surgery patientsO. Old
11:00 AMDiscussion
11:15 AMGlobal burden of foregut IM and adenocarcinomaH. El-Serag
11:45 AMDiscussion
Session 2: Barrett’s I (1.75 CME) Lunch Provided   Moderator: S. DeMeester
12:15 PMPitfalls in the pathologic diagnosis of dysplasia and early EACP. Chandrasoma
12:45 PMDiscussion
1:00 PMCellular and molecular etiology of foregut IM and biomarkers for detection and risk stratificationR. Fitzgerald
1:45 PMDiscussion
2:00 PMAdjourn
2:45 PMHands On Sessions (non-CME)Intro to Manometry
4:00 PMAdjourn
5:30 PMWelcome Reception, All Participants
Friday, February 5
6:00 AMIndustry Break the Fast with Science
Session 3: Barrett’s II (3.0 CME)   Moderator: S. Spechler
7:00 AMNatural history of CIM and short-segment BEH. El-Serag
7:30 AMDiscussion
7:45 AMWhat is BE in 2027 and should the definition be changedS. Komanduri
8:15 AMDiscussion
8:30 AMAntireflux surgery in patients with BE: Indications, outcomes and impact on the natural history of the diseaseO. Old
9:00 AMDiscussion
9:15 AMOptions and outcomes in BE patients with obesityG. Campos
9:45 AMDiscussion
10:00 AMExtended Coffee Break / Case Presentations (snack)
Session 4: Endoscopic Management of Dysplasia and EAC (2.75 CME)   Moderator: D. Katzka
10:45 AMCan endoscopic therapy change the natural history of BE? What the trials and data tell usN. Shaheen
11:15 AMDiscussion
11:30 AMEndoscopic resection for T1b adenocarcinoma (20 minutes each)
Dutch strategy and dataR. Pouw
US strategy and dataF. Schnoll-Sussman
12:15 PMDiscussion
12:30 PMPulling back the curtain: Surgical management of failed endotherapy (20 minutes each)
Dutch data and patient selection for esophagectomyR. van Hillegersberg
MSK experience and pattern of recurrence after surgeryD. Molena
1:15 PMDiscussion
1:30 PMAdjourn
2:00 PMHands On Sessions (non-CME)Advanced Manometry
4:00 PMAdjourn
Saturday, February 6
6:00 AMIndustry Break the Fast with Science / Case Presentation
Session 5: Esophageal Potpourri (2.25 CME)   Moderator: D. Molena
7:00 AMThe EOE epidemic: Drivers and how to manage the diseaseD. Katzka
7:30 AMDiscussion
7:45 AMSecrets to getting the most out of HRM and FLIPJ. Pandolfino
8:15 AMDiscussion
8:30 AMBreak Out Rooms (non-CME)
10:30 AMCoffee Break / Case Presentations
10:45 AMJo Skibby Lecture: A journey over, around and below the Hawaiian Islands (non-CME)Kate Kurtenbach
11:45 AMWho, why and how: PEH repair in 2027S. DeMeester
12:15 PMDiscussion
12:30 PMAdjourn
3:30 PMPoolside Faculty Forum (cases, concepts and idea sharing)
Sunday, February 7  –  FREE DAY
Monday, February 8
6:30 AMContinental Breakfast / Case Presentations
Session 6: BE Screening and Surveillance (3.75 CME)   Moderator: F. Schnoll-Sussman
7:00 AMScreening and surveillance for BE: How did we get to where we are?S. DeMeester
7:30 AMDiscussion
7:45 AMScreening and surveillance for BE: who, how and the promise and limitations of current non-endoscopic optionsR. Fitzgerald
8:15 AMDiscussion
8:30 AMSurveillance and the BOSS trialO. Old
9:00 AMDiscussion
9:15 AMKeys to moving the surveillance needle forwardS. Spechler
9:45 AMHot Seat Discussion (Multiple Faculty)
10:15 AMCoffee Break / Case Presentations (snack)
Session 7: BE Surveillance and Endotherapy (3.0 CME)   Moderator: G. Campos
10:30 AMMissed lesions: how often and what are the consequencesD. Katzka
11:00 AMDiscussion
11:15 AMCan we improve surveillance: AI, p-CLE, Tissue Cypher and other technologiesR. Pouw
11:45 AMDiscussion
12:00 PMWho, when and how to intervene in BEN. Shaheen
12:30 PMDiscussion
12:45 PMHow and for how long: surveillance after endoscopic therapyF. Schnoll-Sussman
1:15 PMDiscussion
1:30 PMAdjourn
6:30 PMCourse Reception
Tuesday, February 9
6:30 AMContinental Breakfast / Case Presentations
Session 8: BE and Endotherapy (3.75 CME)   Moderator: S. Spechler
7:00 AMEtiology and significance of buried Barrett'sR. Souza
7:30 AMDiscussion
7:45 AMCost-effectiveness for BE screening and surveillanceH. El-Serag
8:15 AMDiscussion
8:30 AMManagement of residual or recurrent disease during/after EETR. Pouw
9:00 AMDiscussion
9:15 AMIM at the GEJ after ablation: what is it and does it matterN. Shaheen
9:45 AMHot Seat Discussion (multiple faculty)
10:15 AMCoffee Break / Case Presentations
Session 9: Esophageal Adenocarcinoma (2.25 CME)   Moderator: S. DeMeester
10:30 AMManaging complications of endotherapyS. Komanduri
11:00 AMDiscussion
11:15 AMIs esophagectomy necessary after neoadjuvant therapy and what approach gives the best outcomesR. van Hillegersberg
11:45 AMDiscussion
12:00 PMHow do we improve survival in ≥ T2 adenocarcinomaD. Molena
12:30 PMDiscussion
12:45 PMAdjourn